Position in SABS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$0
+$0 QoQ
Shares Held
3,289
+81.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WOLVERINE ASSET MANAGEMENT LLC holds $7,557,835 across 33 Biotechnology names. SABS ranks #24 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GOSS |
Gossamer Bio, Inc.
|
161,184 | $2,127,633 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
22,340 | $1,771,338 | |
| 3 | 10,909 | $1,447,951 | |||
| 4 | TECH |
BIO-TECHNE Corp
|
10,471 | $739,776 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
2,330 | $561,460 | |
| 6 | NVAX |
Novavax Inc
|
37,037 | $348,888 | |
| 7 | NAMS |
NewAmsterdam Pharma Co N.V.
|
14,925 | $318,947 | |
| 8 | IMCR |
Immunocore Holdings plc
|
2,822 | $89,598 |
All Filings in SABS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2022-09-30 | $2,752 | 3,926 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $5,692 | 3,926 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $24,161 | 6,426 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $51,561 | 6,602 | Shares | Defined | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||